Insulin-like Growth Factor-1 Receptor Inhibitors
- Name
- Insulin-like Growth Factor-1 Receptor Inhibitors
- Accession Number
- DBCAT005492
- Description
Not Available
- Drugs
Drug Drug Description Teprotumumab A fully human monoclonal antibody directed against insulin-like growth factor-1 receptor for the treatment of thyroid eye disease. - Drugs & Drug Targets
Drug Target Type Teprotumumab Insulin-like growth factor 1 receptor target